Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioLife Solutions, Inc. - Common Stock (NQ:BLFS)

26.29 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioLife Solutions, Inc. - Common Stock

< Previous 1 2 3 Next >
BioLife (BLFS) Q3 2025 Earnings Call Transcript
BioLife (BLFS) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
BioLife Solutions Inc (NASDAQ:BLFS) Beats Q3 2025 Earnings and Revenue Estimates
BioLife Solutions Q3 2025 earnings beat estimates with a surprise profit and strong revenue growth, driving a positive market response. 
Via Chartmill
Topics Earnings
Earnings Scheduled For November 6, 2025
 
Via Benzinga
BioLife Solutions Inc (NASDAQ:BLFS) Reports Mixed Q2 2025 Results with Revenue Beat but Profitability Concerns
BioLife Solutions reports Q2 2025 revenue beat but faces profitability challenges, with mixed market reaction. Cell processing growth up 28% YoY. 
Via Chartmill
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Earnings Scheduled For May 8, 2025
 
Via Benzinga
Exploring BioLife Solns's Earnings Expectations
 
Via Benzinga
Analyst Expectations For BioLife Solns's Future
 
Via Benzinga
Earnings Scheduled For November 12, 2024
 
Via Benzinga
Key Takeaways From BioLife Solns Analyst Ratings
 
Via Benzinga
Recap: BioLife Solns Q4 Earnings
 
Via Benzinga
Earnings Scheduled For March 3, 2025
 
Via Benzinga
BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q2 2024
BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q1 2024
BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
Earnings Preview For BioLife Solns
 
Via Benzinga
BioLife Solns: Q3 Earnings Insights
 
Via Benzinga
BioLife Solns: Q1 Earnings Insights
 
Via Benzinga
BioLife Solutions's Earnings Outlook
 
Via Benzinga
Meta Platforms, Pure Storage And 2 Other Stocks Insiders Are Selling
 
Via Benzinga
Over $1M Bet On Carnival? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed mixed on Monday, there were a few notable insider trades. 
Via Benzinga
Top 5 Health Care Stocks That Could Blast Off This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Why Shares of BioLife Solutions Plummeted This Week
The company saw revenue decline, year over year, in the second quarter. 
Via The Motley Fool
Why Shares of BioLife Solutions Are Slumping on Wednesday
The company reported declining revenue and reduced annual guidance. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2023
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.